At a AGM pre Covid days, Board member Prof Bruce Robinson gave a 10 minute run through as to how Nextstellis worked and the differences to other oral contraceptives on the market. It certainly persuaded me that MYX was onto something with this new product. What I had not counted on was the shambolic and costly Nextstellis launch the previous CEO undertook. What a bloody waste of tens of millions.
With current CEO Shawn Patrick O’Brien I feel way more comfortable with his management. Let’s hope for a good update.
Cheers……D
MYX Price at posting:
$7.01 Sentiment: Buy Disclosure: Held
